Pin1 inhibition improves the efficacy of ralaniten compounds that bind to the N-terminal domain of androgen receptor

Lignende værker

• Co-targeting Androgen Receptor Splice Variants and mTOR signaling pathway for the Treatment of Castration-Resistant Prostate Cancer
  af: Kato, Minoru, et al.
  Udgivet: (2015)
• Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
  af: Banuelos, Carmen A., et al.
  Udgivet: (2020)
• Revealing Metabolic Liabilities of Ralaniten To Enhance Novel Androgen Receptor Targeted Therapies
  af: Obst, Jon K., et al.
  Udgivet: (2019)
• Characterization of Niphatenones that Inhibit Androgen Receptor N-Terminal Domain
  af: Banuelos, Carmen A., et al.
  Udgivet: (2014)
• Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
  af: Banuelos, Carmen A., et al.
  Udgivet: (2016)